Biorestorative Therapiesincis A Clinical Stage Biotechnology Company Based In Melvillenew Yorkthe Company Is Dedicated To Developing Regenerative Medicine Therapies Using Adult Stem Cells To Address Unmet Medical Needs In Chronic Pain And Metabolic Disordersits Mission Is To Advance Stem Cell Science To Improve The Quality Of Life For Patients With Degenerative Diseases The Company Is Currently Focused On Several Key Programsbrtx 100 Is In Phase 2 Clinical Trials For Chronic Lumbar Disc Diseaseutilizing Autologous Bone Marrow Derived Mesenchymal Stem Cells To Alleviate Pain And Promote Disc Repairthe Thermostemaprogram Targets Metabolic Disorders Like Obesity And Diabetes By Using Brown Adipose Derived Stem Cells To Enhance Metabolismadditionallybiorestorative Has A Biocosmeceutical Platform That Offers Secretome Based Biologics For Cosmetic Applicationsfocusing On Skin Rejuvenation And Anti Aging Biorestorative Therapies Emphasizes Rigorous Clinical Validation And Operates As A Publicly Traded Entityits Innovative Approach Combines Therapeutic Interventions With Cosmetic Solutionspositioning The Company As A Unique Player In The Regenerative Medicine Field
